FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

17990002: Melarsoprol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
30379013 Melarsoprol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
745355015 Melarsoprol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Melarsoprol Is a Antitrypanosomal drug false Inferred relationship Some
Melarsoprol Is a Substance with antitrypanosomal mechanism of action false Inferred relationship Some
Melarsoprol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antitrypanosomal false Inferred relationship Some
Melarsoprol Is a Triazine derivative (substance) true Inferred relationship Some
Melarsoprol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiprotozoal true Inferred relationship Some
Melarsoprol Is a Antiprotozoal true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing melarsoprol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Melarsoprol Inferred relationship Some 1
Melarsoprol-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Melarsoprol Inferred relationship Some 1
Product containing only melarsoprol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Melarsoprol Inferred relationship Some 1
Melarsoprol only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Melarsoprol Inferred relationship Some 1
Product containing precisely melarsoprol 36 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Melarsoprol Inferred relationship Some 1
Product containing precisely melarsoprol 36 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Melarsoprol Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start